CVS says GLP-1s save money when priced below $350 per month
In short
CVS determined that GLP-1 medications become cost-effective only when priced below $350 per month. At or under this specific financial threshold, the treatments generate net cost savings for payers. Higher price points fail to produce the necessary offsets in healthcare costs.
Key points
- Achieving net financial savings from GLP-1s requires monthly prices below the $350 mark.: Achieving net financial savings from GLP-1s requires monthly prices below the $350 mark.
- Healthcare organizations now have an exact dollar figure to assess GLP-1 cost-effectivene…: Healthcare organizations now have an exact dollar figure to assess GLP-1 cost-effectiveness.
- Drug pricing remains the primary barrier to securing net economic benefits from these med…: Drug pricing remains the primary barrier to securing net economic benefits from these medications.